Evidence map›Paper›PMID 41184958›Full record

ArticleBiology of sex differences2025

Paradoxical sex differences in a hamster model of angiotensin II-dependent hypertension and associated renal injury.

Hong Ji, Laura German do Nascimento, Jungeun Ahn, Dong Hyang Kwon, Gabrielle Williams, Xie Wu, Robert C Speth, Seth A Hawks, Nisha K Duggal, Juan M Saavedra and 2 more

Abstract read
In one paragraph

Article in Biology of sex differences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hong JiDepartment of Medicine, Division of Nephrology and Hypertension, Georgetown University, Washington, DC, USA.
Laura German do NascimentoDepartment of Medicine, Division of Nephrology and Hypertension, Georgetown University, Washington, DC, USA.
Jungeun AhnDepartment of Pathology, Georgetown University, Washington, DC, USA.
Dong Hyang KwonDepartment of Pathology, Georgetown University, Washington, DC, USA.
Gabrielle WilliamsDepartment of Pharmacology & Physiology, Georgetown University, Washington, DC, USA.
Xie WuDepartment of Medicine, Division of Nephrology and Hypertension, Georgetown University, Washington, DC, USA.
Robert C SpethDepartment of Pharmacology & Physiology, Georgetown University, Washington, DC, USA.
Seth A HawksDepartment of Biomedical Sciences and Pathobiology, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA.
Nisha K DuggalDepartment of Biomedical Sciences and Pathobiology, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA.
Juan M SaavedraDepartment of Pharmacology & Physiology, Georgetown University, Washington, DC, USA.
Kathryn SandbergDepartment of Medicine, Division of Nephrology and Hypertension, Georgetown University, Washington, DC, USA.
Aline M A de SouzaDepartment of Medicine, Division of Nephrology and Hypertension, Georgetown University, Washington, DC, USA. aa1617@georgetown.edu.

Funding

Brain pathophysiology in SARS-CoV-2 diseaseR01NS124204 · NINDS · GEORGETOWN UNIVERSITY · PI SANDBERG, KATHRYN L · 2021 to 2025
$3.1M
National Center for Advancing Translational Sciences of the National Institutes of Health KL2TR001432NIH HHS R01NS124204
6 · The paper itself

Abstract

backgroundBiological sex is a critical determinant in cardiovascular and renal disease outcomes. Although angiotensin II (Ang II) infusion is widely used to model hypertension in mice and rats, little is known about its effects in the Syrian hamster, a small rodent increasingly used for translational research. This study aimed to develop a model of chronic Ang II-induced hypertension in Syrian hamsters and investigate sex-specific differences in blood pressure, renal pathology, and components of the renin-angiotensin system (RAS).

methodsMale and female Syrian hamsters (8-9 weeks old) were infused subcutaneously with Ang II (200 ng/kg/min) or saline via osmotic minipumps for four weeks. Mean arterial pressure (MAP) and kidney wet weight were determined on the euthanasia day. The kidneys were analyzed for renal pathology; renal RAS enzymes (ACE and ACE2) were measured by colorimetric assay and qPCR; cytokines (IL-6 and IL-1β) were measured by qPCR; and the angiotensin receptor type 1 (AT1R) was measured by radioligand binding and qPCR.

resultsAng II infusion increased MAP in both sexes but elicited a significantly greater response in females (+ 50 mmHg) than males (+ 27 mmHg, p < 0.005). Female hamsters exhibited pronounced kidney injury, including acute tubular necrosis, glomerular sclerosis, and vascular fibrinoid necrosis, along with a 2-fold increase in kidney weight normalized to body weight. Ang II significantly downregulated renal ACE, ACE2, and AT

conclusionsFemale Syrian hamsters exhibit heightened vulnerability to Ang II-induced hypertension and renal damage compared to males, marked by exaggerated blood pressure elevation, enhanced renal inflammation, and suppression of classical RAS components. This novel hamster model provides a unique platform for studying sex-specific mechanisms of hypertension and renal pathology, with translational relevance for subpopulations of women who are at increased risk of Ang II-dependent hypertension-associated renal disease.

Indexed as

Angiotensin IIHypertensionKidneySex CharacteristicsAnimalsBlood PressureCricetinaeDisease Models, AnimalFemaleMaleMesocricetusReceptor, Angiotensin, Type 1Renin-Angiotensin SystemAngiotensin IIReceptor, Angiotensin, Type 1ACE2Angiotensin IIAT1HypertensionIL-6InflammationKidneyRenin-angiotensin systemSex differencesSyrian hamster

Identifiers

PMID41184958
PMCPMC12581491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.